Literature DB >> 21556812

Acute cortisol release during stereotactic fractionated radiotherapy to an ACTH-secreting pituitary macroadenoma.

I Shimon1, Y Manisterski, A A Kanner.   

Abstract

A 33-year old male was diagnosed with Cushing's disease due to a large and invasive ACTH-secreting macroadenoma. After surgical failure ketoconazole therapy was initiated to control cortisol hypersecretion and his symptoms. He was referred to radiotherapy, and fractionated stereotactic radiotherapy in 30 fractions was delivered. After 12 daily fractions of radiotherapy the urinary cortisol release increased abruptly together with clinical deterioration. The daily ketoconazole dose was increased, and 10 days after concluding radiotherapy his urinary cortisol returned to normal values. Hormonal remission was observed less than 1 year following radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21556812     DOI: 10.1007/s11102-011-0315-2

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  8 in total

1.  Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas.

Authors:  Y Sammy Woo; Andrea M Isidori; Winnie Z Wat; Gregory A Kaltsas; Fari Afshar; Ian Sabin; Paul J Jenkins; John P Monson; G Michael Besser; Ashley B Grossman
Journal:  J Clin Endocrinol Metab       Date:  2005-05-10       Impact factor: 5.958

Review 2.  Cushing's syndrome.

Authors:  John Newell-Price; Xavier Bertagna; Ashley B Grossman; Lynnette K Nieman
Journal:  Lancet       Date:  2006-05-13       Impact factor: 79.321

3.  Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease.

Authors:  F Castinetti; M Nagai; H Dufour; J-M Kuhn; I Morange; P Jaquet; B Conte-Devolx; J Regis; T Brue
Journal:  Eur J Endocrinol       Date:  2007-01       Impact factor: 6.664

4.  Radiosurgery for Cushing's disease after failed transsphenoidal surgery.

Authors:  J M Sheehan; M L Vance; J P Sheehan; D B Ellegala; E R Laws
Journal:  J Neurosurg       Date:  2000-11       Impact factor: 5.115

5.  Transsphenoidal surgery for Cushing's disease.

Authors:  R Fahlbusch; M Buchfelder; O A Müller
Journal:  J R Soc Med       Date:  1986-05       Impact factor: 5.344

6.  The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.

Authors:  J Estrada; M Boronat; M Mielgo; R Magallón; I Millan; S Díez; T Lucas; B Barceló
Journal:  N Engl J Med       Date:  1997-01-16       Impact factor: 91.245

Review 7.  Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

Authors:  B M K Biller; A B Grossman; P M Stewart; S Melmed; X Bertagna; J Bertherat; M Buchfelder; A Colao; A R Hermus; L J Hofland; A Klibanski; A Lacroix; J R Lindsay; J Newell-Price; L K Nieman; S Petersenn; N Sonino; G K Stalla; B Swearingen; M L Vance; J A H Wass; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  2008-04-15       Impact factor: 5.958

8.  Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients.

Authors:  Ilan Shimon; Zvi Ram; Zvi R Cohen; Moshe Hadani
Journal:  Neurosurgery       Date:  2002-07       Impact factor: 4.654

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.